You are here

  • Home
  • Archive
  • Volume 8, Issue 9
  • Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study

Article metrics

Article menu

Download PDFPDF

XML
Infectious diseases
Protocol
Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study

 

Online download statistics by month:

Online download statistics by month: October 2018 to April 2024

AbstractFullPdf
Oct 201822121253
Nov 201815314917
Dec 201817717514
Jan 2019919111
Feb 201958608
Mar 2019525122
Apr 2019474715
May 2019636215
Jun 2019404011
Jul 2019525211
Aug 2019777516
Oct 2019626218
Nov 2019555319
Dec 2019605913
Jan 2020828121
Feb 2020686619
Mar 2020545412
May 2020494959
Jun 2020252430
Jul 2020404043
Aug 2020302925
Sep 2020373114
Oct 2020515025
Nov 2020515124
Dec 2020272511
Jan 2021333129
Feb 202124229
Mar 2021232123
Apr 2021232312
May 2021343216
Jun 202122228
Jul 2021242416
Aug 2021323119
Sep 2021403612
Oct 2021454431
Nov 2021515023
Dec 2021454416
Jan 2022394017
Feb 2022413916
Mar 2022676612
Apr 2022837611
May 2022676314
Jun 2022342914
Jul 202218197
Aug 2022434111
Sep 2022232014
Oct 2022363711
Nov 2022454214
Dec 202279763
Jan 2023509416
Feb 2023676514
Mar 202310510015
Apr 202378757
May 202357537
Jun 202339367
Jul 202344449
Aug 2023454116
Sep 2023444317
Oct 2023384014
Nov 202345467
Dec 2023827816
Jan 2024919110
Feb 202463587
Mar 2024867961
Apr 2024716818
Total369836271125